Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Breunig A et al. | 1993 | intact cell/cell culture, L-929-NCTC cells (mouse L929 fibroblasts), NIH3T3 cells (mouse fibroblasts) | static magnetic field | - |
| Bruckner-Lea C et al. | 1992 | isolated bio./chem. substance, calcium and different dyes | magnetic field, static magnetic field, 50/60 Hz | 156–299 µT |
| Bureau YR et al. | 1992 | animal, rat/Wistar albino | geomagnetic field | - |
| Calabro E et al. | 2011 | intact cell/cell culture, human neuroblastoma cell line (SH-SY5Y) | magnetic field, static magnetic field, 50/60 Hz | 1–2 mT |
| Calabrò E et al. | 2017 | isolated bio./chem. substance, different hemoglobin aqueous solutions | static magnetic field, co-exposure, also other exposures without EMF | - |
| Calabrò E et al. | 2018 | isolated bio./chem. substance, hemoglobin aqueous solution | static magnetic field, magnetic field, 50/60 Hz | - |
| Calabrò E et al. | 2018 | isolated bio./chem. substance, human hemoglobin | static magnetic field, DC, also other exposures without EMF | - |
| Carter CS et al. | 2020 | animal, 3 mouse models for type 2 diabetes | static magnetic field, static electric field, co-exposure | - |
| Catallo N et al. | 2010 | isolated bio./chem. substance, aqueous solution of ascorbic acid and Fremy's salt (potassium nitrosodisulfonate) | static magnetic field | 0.5–350 mT |
| Cepeda MS et al. | 2007 | animal, partial body | static magnetic field, therapeutic/medical device | 190 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
